EYE CANCER
Clinical trials for EYE CANCER explained in plain language.
Never miss a new study
Get alerted when new EYE CANCER trials appear
Sign up with your email to follow new studies for EYE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye injection could shrink metastatic tumors in the eye
Disease control Recruiting nowThis Phase 2 trial tests a drug called belzupacap sarotalocan (AU-011) for people whose cancer has spread to the choroid, the layer of blood vessels in the eye. The drug is injected into the eye and then activated with a laser. The study aims to see if it is safe and can shrink o…
Matched conditions: EYE CANCER
Phase: PHASE2 • Sponsor: Aura Biosciences • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New capsule aims to fight rare eye cancer that spreads
Disease control Recruiting nowThis study tests an experimental drug called NBM-BMX in people with metastatic uveal melanoma, a rare eye cancer that has spread to other parts of the body. The goal is to find the best dose, check for side effects, and see if the drug can shrink or slow tumors. Participants take…
Matched conditions: EYE CANCER
Phase: PHASE1, PHASE2 • Sponsor: Novelwise Pharmaceutical Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC